Kadmus Pharmaceuticals, Inc.




Kadmus Pharmaceuticals is actively seeking partnership(s) for the KDS-5000 program, the series of OEA-based pharmaceutical and nutraceutical products.  Administration of OEA can result in weight reduction, lower food intake and improvement of various lipid profiles (i.e. in blood and in liver).  For more information, please contact us at the address below.


Kadmus Pharmaceuticals, Inc.
partnering@kadmuspharma.com



Thank you for your interest.